GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Total Equity

Telcon RF Pharmaceutical (XKRX:200230) Total Equity : ₩83,135 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Total Equity?

Telcon RF Pharmaceutical's total equity for the quarter that ended in Dec. 2024 was ₩83,135 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Telcon RF Pharmaceutical Total Equity Historical Data

The historical data trend for Telcon RF Pharmaceutical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Total Equity Chart

Telcon RF Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91,475.48 106,607.65 84,135.31 104,944.53 83,134.90

Telcon RF Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104,944.53 97,579.03 92,422.23 95,528.81 83,134.90

Telcon RF Pharmaceutical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Telcon RF Pharmaceutical's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=153588.08-70453.178
=83,135

Telcon RF Pharmaceutical's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=153588.08-70453.178
=83,135

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telcon RF Pharmaceutical Total Equity Related Terms

Thank you for viewing the detailed overview of Telcon RF Pharmaceutical's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Telcon RF Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102
Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It develops connectors for input and output ports, board-to-board, cable assembly, and board-to-mount used in wireless communication equipment. The company also supplies RF coaxial connectors. The company operates in the RF Division and Pharmaceuticals & Biotechnology segments. The majority of its revenue is generated from Pharmaceuticals & Biotechnology, which produces and sells liquids, tablets, pills, capsules, etc.

Telcon RF Pharmaceutical Headlines

No Headlines